Merck to expand dangerous Gardasil vaccine to women and men ages 27 to 45
Gardasil vaccine manufacturer, Merck, announced earlier this month (June, 2018) that the U.S. Food and Drug Administration (FDA) has granted them a “Priority Review” to approve the dangerous and controversial Gardasil 9 vaccine to women and men, ages 27 to 45.
Posted 6/6/2018 • CommentsShare
Tagged Under: Vaccines, Merck, Gardasil, FDA